Professor Dr. Shelagh Coutts

Biography

Shelagh Coutts completed her undergraduate medical degree at the University of Edinburgh in 1997, after which she undertook general medical training at Glasgow Royal Infirmary and specialized in neurology. She moved to Calgary to complete her Fellowship in Stroke Neurology under Dr. Alastair Buchan, completing her Neurology Residency Training and receiving FRCPC (Neurology) in 2006. Dr. Coutts has an extensive background in clinical trials, having completed her MSc in Clinical Trials with distinction at the London School of Hygiene and Tropical Medicine in 2013. As a full professor in the Departments of Clinical Neurosciences, Radiology, and Community Health Sciences at the University of Calgary, she is a strong advocate for increasing female representation in stroke research and is the founder of CANWIN (Canadian Women in Stroke). Her research interests focus on the diagnosis, triage, and treatment of TIA and minor stroke patients, using imaging techniques to identify those who would benefit from treatment. Dr. Coutts has been involved in multiple international clinical trials related to acute stroke and stroke prevention, including the TEMPO-2 study, published in the Lancet. She has received numerous accolades for her work, including the Siekert New Investigator Award from the American Stroke Association and the Michael J. Pessin Award for Stroke Leadership from the American Academy of Neurology.

Research Interests

Awards